Opaganib Protects against Radiation Toxicity: Implications for Homeland Security and Antitumor Radiotherapy by Lynn W. Maines, Randy S. Schrecengost, Yan Zhuang, Staci N. Keller, Ryan A. Smith, Cecelia L. Green, Charles D. Smith

Get full text

The Sphingolipid-Modulating Drug Opaganib Protects against Radiation-Induced Lung Inflammation and Fibrosis: Potential Uses as a Medical Countermeasure and in Cancer Radiotherapy by Lynn W. Maines, Staci N. Keller, Ryan A. Smith, Cecelia L. Green, Charles D. Smith

Get full text

Systemic pain relief after omalizumab injection in patient with hypermobile Ehlers–Danlos syndrome: A case report by Sarahrose Jonik, Andrew Joseph Rothka, Neyha Cherin

Get full text

685 A first-in-human Phase 1/2 clinical trial of SIRPαlow activated macrophages (SIRPant-M) for the treatment of R/R-NHL by Koby Kidder, Rita N Barcia, Stephen Fogelson, Candida Fratazzi, Nathanael McCurley

Opaganib (ABC294640) Induces Immunogenic Tumor Cell Death and Enhances Checkpoint Antibody Therapy by Lynn W. Maines, Staci N. Keller, Charles D. Smith

Get full text

The Sphingosine Kinase 2 Inhibitor Opaganib Protects Against Acute Kidney Injury in Mice by Maines LW, Green CL, Keller SN, Fitzpatrick LR, Smith CD

“…Lynn W Maines, Cecelia L Green, Staci N Keller, Leo R Fitzpatrick, Charles D Smith Apogee Biotechnology Corporation, Hummelstown, PA, USACorrespondence: Charles D Smith, Apogee Biotechnology Corporation, 1214 Research Blvd, Suite 2015, Hummelstown, PA, 17036, USA, Email cdsmith@apogee-biotech.comIntroduction: Acute kidney injury (AKI) is a common multifactorial adverse effect of surgery, circulatory obstruction, sepsis or drug/toxin exposure that often results in morbidity and mortality. …”
Get full text

Nitrogen and Phosphorus Concentration Thresholds toward Establishing Water Quality Criteria for Pennsylvania, USA by John W. Clune, J. Kent Crawford, Elizabeth W. Boyer

Get full text